UNSW Founders and The George Institute for Global Health have partnered to deliver a unique national program accelerating the business growth of startups developing affordable and scalable solutions for major health challenges, particularly the growing burden of non-communicable diseases (NCDs) and injury in underserved populations.
Health 10x is a unique accelerator program designed and delivered by the University of New South Wales (UNSW) in partnership with The George Institute for Global Health (TGI). This partnership allows participants to leverage the global health expertise of TGI, and the entrepreneurial experience and global networks of UNSW’s Founders team.
Health 10x startups will receive entrepreneurship education and coaching tailored to their level of business development, along with dedicated health modules delivered by subject matter experts from TGI.
The program will run in conjunction with the 10x Accelerator (for industry agnostic teams).
Health 10x is a two-phase program (Pre-Accelerator and Accelerator).
All teams accepted into Health 10x will participate in the 5-week Health 10x Pre-Accelerator, and up to 6 teams will be selected to advance to the 10-week Health 10x Accelerator.
All program participants will benefit from:
Accelerated startup education from leading industry experts and founders
Dedicated HealthTech commercialisation modules, including ‘Clinical Trials’ and ‘Health Economics’ and others, developed by TGI and delivered by key opinion leaders in the field
Practical advice and coaching
Validation of your business idea, solution or research application
The opportunity to build, refine or scale your business model and become investment ready
Networking and peer- to- peer support to build your confidence and networks
Access to UNSW pool of talent: interns and study placements
Access to UNSW world-class network of makerspaces to ideate and prototype being guided/supported by the dedicated UNSW prototyping coaches
Access to UNSW Founders Perks up to the value of $1M
Access to a pool of $15,000 in program prizes
If you are accepted into the Health 10x Accelerator, you’ll also receive:
$20,000 seed funding as a SAFE agreement (meet startups who received the investment here)
10 weeks of accelerated learning from industry and startup experts via workshops, mentoring and collaborative activities
Access to the Health10x global mentorship program: Meet Health 10x cohort #2 2020 mentors here
Weekly 1:1 meetings with our Entrepreneur-in-Residence
An opportunity to participate in a series of digital events with key health innovation stakeholders in Australia, India and America
UNSW Founders Alumni Program: Access to a co-working space with UNSW Founders in Residence for 6 months after the program, ongoing mentorship & coaching, networking and educational events
An opportunity to pitch your startup to investors at the Health 10x Demo Night – Watch the 2020 Health 10x 2020 Demo Night here
Access to R&D expertise – UNSW staff, students (HDR and UG) and facilities
Ongoing media and PR support
Founders and co-founders of startups whose product or service addresses non-communicable diseases or injury and can be applied in underserved markets.
Founders focused on making a social impact.
Founders who want to become more resilient, learn how to build traction and scale
Founders who want to participate in an intensive modular program. Each week you’ll learn new startup frameworks to practice and implement.
Founders keen to access UNSW’s and TGI's outstanding network of founders, alumni and mentors with domain expertise.
If this sounds like you but you aren’t specifically health focused please check out our Founders 10x Accelerator program.
You are a founder or co-founder of a currently operating startup
You have a proof of concept, prototype or MVP
You have some market validation through customer take- up or engagement
You can commit to participating in the program for the full 15 weeks (1 day per week in the 5 week Pre-Accelerator Program and approximately 12 hours per week during the 10 week Accelerator phase)
You have an Australian registered company (Pty Ltd) to enter the accelerator phase of the program
You are prepared to sign the Founders’ Pledge to give back to the UNSW Entrepreneurship community
Applications open 1 April 2022
Info Night TBA
Applications close 15 May 2022
Selected teams notified 8 August 2022
Health 10x Pre-Accelerator
Program commences 30 May 2022
Program concludes 24 June 2022
Health 10x Accelerator
Program selection interviews for 10 teams 11 July 2022
Program commences with Bootcamp 18 August 2022
Program concludes 26 October 2022
Demo Night 9 November 2022
Public Showcase 16 November 2022
Please meet Health 10x Accelerator participants 2019-2020 here
Eugene Salole PhD MPH
Principal, Value-Based Access Pty Ltd, Sydney
& Adjunct Professor, Faculty of Medicine, UNSW Sydney
Eugene Salole is principal at Value-Based Access Pty Ltd (VBA), a Sydney consultancy specialising in ‘value-based healthcare’ – specifically, the acquisition of reimbursement/funding, ‘market access’, for innovative health technologies, by expressing their value to healthcare providers, healthcare systems and payers. Prior to founding VBA in 2013, Eugene held senior market access positions in multinational medical device and pharmaceutical companies; his other professional experience includes capability-building consultancy to the WHO Essential Drugs Programme in sub-Saharan Africa, and pro bono advisory work for the Australian CSIRO and UK Department of Health. Eugene is also privileged to serve as Adjunct Professor in the Faculty of Medicine, UNSW Sydney.
A SAFE note, or a Simple Agreement for Future Equity, is an agreement for an investor to make a cash investment into a company in return for shares at a later date in connection with a specific event
Example events include: exit sales, IPO or funding rounds
SAFE is not a debt instrument and is intended to be an alternative to convertible notes.
How it works
Investor and investee company agree on a valuation cap and/or a discount rate
Investor pays company investment amount
•Outstanding SAFE is referenced on the company’s capitalisation table like any other convertible securities
At triggering event, cash investment is converted into equity
Who uses it
SAFE notes are intended for investment into very early-stage companies as they allow for investment before the valuation of the company is set
It is also a tool for investors to use to invest in a company quickly, closing a deal where there is high funding competition and the investor does not wish to wait for the valuation price to be negotiated and finalised, especially where there are multiple investors in a funding round. This use is more common in the US than Australia.
Please contact the Health 10x Program Managers: Dina Titkova (UNSW Founders) and Vesna Todorovski (The George Institute)
